Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.69 is 32% above its 5-year average of 3.54, around the middle of its 5-year range (0.00–7.32).
As of the fiscal period ended Friday, July 31, 2026. 18.40% below its 12-month average of 5.74.
Reported quarterly current ratio; no daily interpolation. Q1 FY2027 (2026-07-31): 4.69.
CURRENT RATIO
4.69
CURRENT RATIO AVG TTM
5.74
CURRENT RATIO AVG 3Y
3.68
CURRENT RATIO AVG 5Y
3.54
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-18.40%
CURRENT VS 3Y AVG
+27.27%
CURRENT VS 5Y AVG
+32.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.58
median of 762 covered companies
CURRENT VS SECTOR MEDIAN
+30.94%
vs the sector median at left
Kestra Medical Technologies, Ltd.
Market Cap
$1.61B
Current Ratio
4.69
TTM Avg
5.74
3Y Avg
3.68
5Y Avg
3.54
Market Cap
$1.62B
Current Ratio
13.11
TTM Avg
13.03
3Y Avg
9.21
5Y Avg
8.89
Market Cap
$1.63B
Current Ratio
2.91
TTM Avg
2.71
3Y Avg
3.12
5Y Avg
3.05
Market Cap
$1.56B
Current Ratio
6.77
TTM Avg
5.11
3Y Avg
9.27
5Y Avg
12.43
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. (KMTS) | $1.61B | 4.69 | 5.74 | 3.68 | 3.54 |
| Omnicell, Inc. (OMCL)vs › | $1.60B | 1.64 | 1.40 | 1.84 | 1.88 |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.62B | 13.11 | 13.03 | 9.21 | 8.89 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 2.91 | 2.71 | 3.12 | 3.05 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 1.89 | 2.40 | 2.37 | 2.65 |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.56B | 6.77 | 5.11 | 9.27 | 12.43 |
| Septerna Inc (SEPN)vs › | $1.66B | 4.99 | 16.25 | 13.64 | 13.64 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 16.01 | 8.50 | 7.33 | 23.22 |
| uniQure N.V. (QURE)vs › | $1.54B | 10.01 | 10.09 | 8.82 | 10.31 |
| Nutex Health, Inc. (NUTX)vs › | $1.54B | 5.00 | 2.75 | 2.21 | 2.87 |
Current Ratio
4.69
Quick Ratio
4.69
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-07-31 | 4.69 |
| 2026-04-30 | 4.41 |
| 2026-01-31 | 7.32 |
| 2025-10-31 | 5.47 |
| 2025-07-31 | 6.84 |
| 2025-04-30 | 6.72 |
| 2025-01-31 | 1.81 |
| 2024-10-31 | 2.81 |
| 2024-07-31 | 0.00 |
| 2024-04-30 | 0.45 |
| 2024-01-31 | 0.00 |
| 2021-07-31 | 2.00 |
